Literature DB >> 10537017

Do sunscreens increase or decrease melanoma risk: an epidemiologic evaluation.

M A Weinstock1.   

Abstract

Ultraviolet adiation is an important cause of melanoma, so the use of sunscreen lotions has been advocated for melanoma prevention. Several arguments have been raised in opposition to this inference. Sunscreen use may interfere with cutaneous vitamin D synthesis, which some have hypothesized may lower melanoma risk. Sunscreen users may compensate for their sunscreen use by staying out much longer in the sun, or may use sunscreen lotions inconsistantly. Published melanoma case-control studies have not consistantly demonstrated a protective effect of sunscreens; however, these studies do not provide strong evidence, ultraviolet radiation is a known cause of melanoma, and ultraviolet B may be particularly potent, so on balance the evidence supports continued advocacy of sunscreen lotion use as part of an overall sun-protection regimen. Uncertainty will remain, however, until the action spectrum of melanoma is convincingly demonstrated or the methodologic limitations of existing epidemiologic evidence are overcome. The latter may require another decade or more of experience with sunscreen use.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537017     DOI: 10.1038/sj.jidsp.

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  7 in total

Review 1.  Molecular mechanisms of inhibition of photocarcinogenesis by silymarin, a phytochemical from milk thistle (Silybum marianum L. Gaertn.) (Review).

Authors:  Mudit Vaid; Santosh K Katiyar
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

Review 2.  Regional treatment strategies for in-transit melanoma metastasis.

Authors:  Ryan S Turley; Amanda K Raymond; Douglas S Tyler
Journal:  Surg Oncol Clin N Am       Date:  2011-01       Impact factor: 3.495

3.  An Overview of Ultraviolet B Radiation-Induced Skin Cancer Chemoprevention by Silibinin.

Authors:  Rahul Kumar; Gagan Deep; Rajesh Agarwal
Journal:  Curr Pharmacol Rep       Date:  2015-06-01

4.  Adjuvant high-dose interferon-{alpha} for resected melanoma in a patient with HIV infection.

Authors:  Nakhle S Saba; Thomas J George; Brian C Boulmay
Journal:  Oncologist       Date:  2010-06-16

Review 5.  Chemoprevention of melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Adv Pharmacol       Date:  2012

Review 6.  Associations between environmental factors and incidence of cutaneous melanoma. Review.

Authors:  Katarina Volkovova; Dagmar Bilanicova; Alena Bartonova; Silvia Letašiová; Maria Dusinska
Journal:  Environ Health       Date:  2012-06-28       Impact factor: 5.984

Review 7.  Pharmacologic manipulation of skin pigmentation.

Authors:  Gabriel H Kindl; John A D'Orazio
Journal:  Pigment Cell Melanoma Res       Date:  2021-03-12       Impact factor: 4.159

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.